EDGAR Filing Documents for 0001213900-21-032329

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-21-032329

Filing Date

2021-06-14

Accepted

2021-06-14 17:00:21

Documents

Period of Report

2021-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2021_elitepharma.htm	10-K	1390528
2	EMPLOYMENT AGREEMENT WITH DOUGLAS PLASSCHE	f10k2021ex10-52_elitepharma.htm	EX-10.52	22974
3	JUNE 21, 2019 RETENTION AGREEMENT WITH DOUGLAS PLASSCHE	f10k2021ex10-53_elitepharma.htm	EX-10.53	11944
4	JULY 29, 2019 AMENDMENT TO THE LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT BETWEE	f10k2021ex10-54_elitepharma.htm	EX-10.54	47114
5	CONSENT OF BUCHBINDER TUNICK & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUN	f10k2021ex23-1_elitepharma.htm	EX-23.1	2533
6	CERTIFICATION	f10k2021ex31-1_elitepharma.htm	EX-31.1	9830
7	CERTIFICATION	f10k2021ex31-2_elitepharma.htm	EX-31.2	9813
8	CERTIFICATION	f10k2021ex32-1_elitepharma.htm	EX-32.1	4267
9	CERTIFICATION	f10k2021ex32-2_elitepharma.htm	EX-32.2	4464
10	GRAPHIC	ex10-52_001.jpg	GRAPHIC	43219
11	GRAPHIC	ex10-53_001.jpg	GRAPHIC	9087
	Complete submission text file	0001213900-21-032329.txt		5919511

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE FILE	eltp-20210331.xml	EX-101.INS	764106
13	XBRL SCHEMA FILE	eltp-20210331.xsd	EX-101.SCH	91961
14	XBRL CALCULATION FILE	eltp-20210331_cal.xml	EX-101.CAL	38177
15	XBRL DEFINITION FILE	eltp-20210331_def.xml	EX-101.DEF	323025
16	XBRL LABEL FILE	eltp-20210331_lab.xml	EX-101.LAB	641335
17	XBRL PRESENTATION FILE	eltp-20210331_pre.xml	EX-101.PRE	334007

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)